Jin HS - Search Results

1

Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.

Jo Y, Sim HI, Yun B, Park Y, Jin HS. Jo Y, et al. Among authors: jin hs. Exp Mol Med. 2024 Oct;56(10):2113-2126. doi: 10.1038/s12276-024-01317-9. Epub 2024 Oct 1. Exp Mol Med. 2024. PMID: 39349829 Free PMC article. Review.

2

Neddylation pathway regulates T-cell function by targeting an adaptor protein Shc and a protein kinase Erk signaling.

Jin HS, Liao L, Park Y, Liu YC. Jin HS, et al. Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):624-9. doi: 10.1073/pnas.1213819110. Epub 2012 Dec 24. Proc Natl Acad Sci U S A. 2013. PMID: 23267066 Free PMC article.

3

Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex.

Park Y, Jin HS, Liu YC. Park Y, et al. Among authors: jin hs. Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9433-8. doi: 10.1073/pnas.1221925110. Epub 2013 May 20. Proc Natl Acad Sci U S A. 2013. PMID: 23690623 Free PMC article.

4

SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex.

Park Y, Jin HS, Lopez J, Lee J, Liao L, Elly C, Liu YC. Park Y, et al. Among authors: jin hs. Nat Immunol. 2016 Mar;17(3):286-96. doi: 10.1038/ni.3352. Epub 2016 Feb 1. Nat Immunol. 2016. PMID: 26829767 Free PMC article.

5

Extracellular pH modulating injectable gel for enhancing immune checkpoint inhibitor therapy.

Jin HS, Choi DS, Ko M, Kim D, Lee DH, Lee S, Lee AY, Kang SG, Kim SH, Jung Y, Jeong Y, Chung JJ, Park Y. Jin HS, et al. J Control Release. 2019 Dec 10;315:65-75. doi: 10.1016/j.jconrel.2019.10.041. Epub 2019 Oct 25. J Control Release. 2019. PMID: 31669264 Free article.

6

CD226^hiCD8⁺ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.

Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y. Jin HS, et al. Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7. Cancer Immunol Res. 2020. PMID: 32265229

7

Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy.

Jin HS, Park Y. Jin HS, et al. BMB Rep. 2021 Jan;54(1):2-11. doi: 10.5483/BMBRep.2021.54.1.229. BMB Rep. 2021. PMID: 33298247 Free PMC article. Review.

8

The deubiquitinase CYLD controls protective immunity against helminth infection by regulation of Treg cell plasticity.

Lee JH, Zou L, Yang R, Han J, Wan Q, Zhang X, El Baghdady S, Roman A, Elly C, Jin HS, Park Y, Croft M, Liu YC. Lee JH, et al. Among authors: jin hs. J Allergy Clin Immunol. 2021 Jul;148(1):209-224.e9. doi: 10.1016/j.jaci.2020.10.042. Epub 2020 Dec 10. J Allergy Clin Immunol. 2021. PMID: 33309741 Free PMC article.

9

GSK3 Restrains Germinal Center B Cells to Form Plasma Cells.

Lee J, Park H, Lim J, Jin HS, Park Y, Jung YJ, Ko HJ, Yoon SI, Lee GS, Kim PH, Choi SS, Xiao C, Kang SG. Lee J, et al. Among authors: jin hs. J Immunol. 2021 Feb 1;206(3):481-493. doi: 10.4049/jimmunol.2000908. Epub 2020 Dec 21. J Immunol. 2021. PMID: 33380497 Free article.

10

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.

Yeo J, Ko M, Lee DH, Park Y, Jin HS. Yeo J, et al. Among authors: jin hs. Pharmaceuticals (Basel). 2021 Feb 28;14(3):200. doi: 10.3390/ph14030200. Pharmaceuticals (Basel). 2021. PMID: 33670993 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters